Chuanhui Cao Selected Research

Ubiquitin-Conjugating Enzymes

1/2022

UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chuanhui Cao Research Topics

Disease

8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2015
8	Neoplasms (Cancer) 01/2022 - 09/2012
2	Bites and Stings (Sting) 01/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 06/2019 - 03/2016
2	Carcinogenesis 10/2012 - 09/2012
1	Nasopharyngeal Carcinoma 03/2016
1	Carcinoma (Carcinomatosis) 10/2012
1	Esophageal Neoplasms (Esophageal Cancer) 10/2012
1	Fibrosis (Cirrhosis) 09/2012

Drug/Important Bio-Agent (IBA)

4	CateninsIBA 01/2022 - 03/2016
3	Long Noncoding RNAIBA 06/2019 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2018 - 02/2015
2	Small Nucleolar RNA (snoRNA)IBA 02/2016 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 10/2012 - 09/2012
1	Dihydroorotate DehydrogenaseIBA 01/2022
1	Ubiquitin-Conjugating EnzymesIBA 01/2022
1	pyrimidineIBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Therapeutic UsesIBA 01/2021
1	ICG 001IBA 01/2021
1	ceralasertibIBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	InterferonsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	MK 2206IBA 03/2016
1	Untranslated RNA (Noncoding RNA)IBA 02/2015
1	Messenger RNA (mRNA)IBA 10/2012
1	Protein Kinases (Protein Kinase)IBA 10/2012
1	Casein Kinases (Casein Kinase)IBA 10/2012
1	Transcription Factor 4IBA 09/2012
1	Transcription Factors (Transcription Factor)IBA 09/2012

Therapy/Procedure

3	Radiotherapy 01/2021 - 01/2020
2	Therapeutics 01/2021 - 01/2020
1	Secondary Prevention 01/2021
1	Radioimmunotherapy 01/2020